BEONE MEDICINES LTD. Cash and Cash Equivalents
BEONE MEDICINES LTD. (ONC) had Cash and Cash Equivalents of $5.10 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $5.10B.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.79B.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $4.55B.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.04B.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $5.10B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.79B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $4.55B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $4.04B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.76B 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $2.52B 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $2.63B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.70B 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $2.59B 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $2.79B 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $3.17B 10-K · filed 2026-02-26 | |
| 2023-09-30 | $3.07B 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.41B 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $3.54B 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $3.87B 10-K · filed 2025-02-27 | |
| 2022-09-30 | $4.20B 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $4.53B 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $4.35B 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $4.38B 10-K · filed 2024-02-26 | |
| 2021-09-30 | $1.38B 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.78B 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $1.90B 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $1.38B 10-K · filed 2023-02-27 | |
| 2020-09-30 | $1.46B 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.35B 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $1.96B 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $618.01M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $856.85M 10-Q · filed 2020-11-05 | $856.15M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $918.95M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $764.49M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $712.94M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $643.49M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $438.42M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $490.63M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $239.60M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $208.51M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $261.01M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $97.75M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $87.51M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $85.53M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $58.08M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $208.51M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $17.87M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $27.45M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $25.16M 10-Q · filed 2016-08-10 | |
| 2015-03-31 | $13.37M 10-Q · filed 2016-05-12 | |
| 2014-12-31 | $13.90M 10-K · filed 2018-02-28 | |
| 2013-12-31 | $3.93M 10-K · filed 2017-03-22 |